![A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trial | British Journal of A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trial | British Journal of](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.bjc.6602682/MediaObjects/41416_2005_Article_BF6602682_Fig1_HTML.gif)
A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trial | British Journal of
![Effects of BEP treatment at 9 wk and following a 9-wk recovery period... | Download Scientific Diagram Effects of BEP treatment at 9 wk and following a 9-wk recovery period... | Download Scientific Diagram](https://www.researchgate.net/profile/Bernard-Robaire/publication/221688891/figure/fig2/AS:326854645960717@1454939628971/Effects-of-BEP-treatment-at-9-wk-and-following-a-9-wk-recovery-period-on-histone-protein_Q640.jpg)
Effects of BEP treatment at 9 wk and following a 9-wk recovery period... | Download Scientific Diagram
![Cells | Free Full-Text | miR-371a-3p, miR-373-3p and miR-367-3p as Serum Biomarkers in Metastatic Testicular Germ Cell Cancers Before, During and After Chemotherapy Cells | Free Full-Text | miR-371a-3p, miR-373-3p and miR-367-3p as Serum Biomarkers in Metastatic Testicular Germ Cell Cancers Before, During and After Chemotherapy](https://pub.mdpi-res.com/cells/cells-08-01221/article_deploy/html/images/cells-08-01221-g004.png?1572501594)
Cells | Free Full-Text | miR-371a-3p, miR-373-3p and miR-367-3p as Serum Biomarkers in Metastatic Testicular Germ Cell Cancers Before, During and After Chemotherapy
![IJMS | Free Full-Text | Exposure to Chemotherapy During Childhood or Adulthood and Consequences on Spermatogenesis and Male Fertility IJMS | Free Full-Text | Exposure to Chemotherapy During Childhood or Adulthood and Consequences on Spermatogenesis and Male Fertility](https://pub.mdpi-res.com/ijms/ijms-21-01454/article_deploy/html/images/ijms-21-01454-g001.png?1583598193)
IJMS | Free Full-Text | Exposure to Chemotherapy During Childhood or Adulthood and Consequences on Spermatogenesis and Male Fertility
![A Randomised Phase 2 Trial of Intensive Induction Chemotherapy (CBOP/BEP) and Standard BEP in Poor-prognosis Germ Cell Tumours (MRC TE23, CRUK 05/014, ISRCTN 53643604) - ScienceDirect A Randomised Phase 2 Trial of Intensive Induction Chemotherapy (CBOP/BEP) and Standard BEP in Poor-prognosis Germ Cell Tumours (MRC TE23, CRUK 05/014, ISRCTN 53643604) - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0302283814006083-gr2.jpg)
A Randomised Phase 2 Trial of Intensive Induction Chemotherapy (CBOP/BEP) and Standard BEP in Poor-prognosis Germ Cell Tumours (MRC TE23, CRUK 05/014, ISRCTN 53643604) - ScienceDirect
![How to Manage Cisplatin-Based Chemotherapy–Related Cardiovascular Disease in Patients With Testicular Cancer | JACC: CardioOncology How to Manage Cisplatin-Based Chemotherapy–Related Cardiovascular Disease in Patients With Testicular Cancer | JACC: CardioOncology](https://www.jacc.org/cms/asset/1fddde24-aab3-4afe-9282-153efdaa287a/fx1.jpg)
How to Manage Cisplatin-Based Chemotherapy–Related Cardiovascular Disease in Patients With Testicular Cancer | JACC: CardioOncology
![Toxicities Associated with Cisplatin-Based Chemotherapy and Radiotherapy in Long-Term Testicular Cancer Survivors Toxicities Associated with Cisplatin-Based Chemotherapy and Radiotherapy in Long-Term Testicular Cancer Survivors](https://static-02.hindawi.com/articles/au/volume-2018/8671832/figures/8671832.fig.001.jpg)
Toxicities Associated with Cisplatin-Based Chemotherapy and Radiotherapy in Long-Term Testicular Cancer Survivors
![Bleomycin, vincristine, cisplatin/bleomycin, etoposide, cisplatin chemotherapy: an alternating, dose intense regimen producing promising results in untreated patients with intermediate or poor prognosis malignant germ-cell tumours | British Journal of ... Bleomycin, vincristine, cisplatin/bleomycin, etoposide, cisplatin chemotherapy: an alternating, dose intense regimen producing promising results in untreated patients with intermediate or poor prognosis malignant germ-cell tumours | British Journal of ...](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.bjc.6601528/MediaObjects/41416_2004_Article_BF6601528_Fig1_HTML.gif)
Bleomycin, vincristine, cisplatin/bleomycin, etoposide, cisplatin chemotherapy: an alternating, dose intense regimen producing promising results in untreated patients with intermediate or poor prognosis malignant germ-cell tumours | British Journal of ...
![Survival and reproductive function of 52 women treated with surgery and bleomycin, etoposide, cisplatin (BEP) chemotherapy for ovarian yolk sac tumor - ScienceDirect Survival and reproductive function of 52 women treated with surgery and bleomycin, etoposide, cisplatin (BEP) chemotherapy for ovarian yolk sac tumor - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0923753419402573-gr1.jpg)
Survival and reproductive function of 52 women treated with surgery and bleomycin, etoposide, cisplatin (BEP) chemotherapy for ovarian yolk sac tumor - ScienceDirect
![A Randomised Phase 2 Trial of Intensive Induction Chemotherapy (CBOP/BEP) and Standard BEP in Poor-prognosis Germ Cell Tumours (MRC TE23, CRUK 05/014, ISRCTN 53643604) - ScienceDirect A Randomised Phase 2 Trial of Intensive Induction Chemotherapy (CBOP/BEP) and Standard BEP in Poor-prognosis Germ Cell Tumours (MRC TE23, CRUK 05/014, ISRCTN 53643604) - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0302283814006083-gr1.jpg)